Scott Moseley

Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia

Michael P. Whyte, Cheryl R. Greenberg, Keiichi Ozono et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 265 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +16

Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)

Julie Bernhardt, Leonid Churilov, Fiona Ellery et al. · Neurology · 2016 · 217 citations · Full text

Medicine, Rehabilitation Medicine, Geriatric Rehabilitation +14

Asfotase alfa therapy for children with hypophosphatasia

Michael P. Whyte, Katherine L. Madson, Dawn Phillips et al. · JCI Insight · 2016 · 172 citations · Full text

Medicine, Molecular Medicine, Bone Metabolism +15

Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial

Michael P. Whyte, Jill H. Simmons, Scott Moseley et al. · The Lancet Diabetes & Endocrinology · 2018 · 145 citations

Medicine, Child Health, Pediatrics +4

Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia

Priya S. Kishnani, Cheryl R. Greenberg, Frank Rauch et al. · Bone · 2018 · 144 citations · Full text

Medicine, Biochemistry, Pharmacotherapy +17